海外の悪性黒色腫専門医 — ページ3

Dr. Nail Paksoy is an associate professor of medical oncology at Medipol Bahçelievler Hospital. He is board-certified by the European Society for Medical Oncology (ESMO). Dr. Paksoy specializes in lung, breast, and gastrointestinal cancers. He uses modern immunotherapy and targeted therapy protocols. His clinic is JCI-accredited for high safety standards.

• Served as a subinvestigator in over 8 international clinical trials for Roche and Pfizer.
• Authored over 40 research articles in journals indexed by SCI and SSCI.
• Completed dual fellowships in allergy-immunology and medical oncology.
• Treats complex sarcomas and renal cell carcinomas with systemic therapies.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Education

Sep 2009 – Jun 2014      Medical Degree - Doctor of Medicine and Surgery (MD)

                                                University of Malta

Sep 2006 – Jun 2009      Bachelor of Science in Pharmaceutical Sciences (BSc Honours)

                                                University of East Anglia (United Kingdom)

Work Experience and Training

Aug 2021 – Aug 2022   Senior Skin Cancer Fellow

                                               St John’s Institute of Dermatology, Guy’s and St Thomas’ hospitals

                                               King’s College London, UK

Sep 2017 – Sep 2020    Dermatology and Venerology Specialty Trainee

                                               Sheba Medical Centre, Tel-Hashomer

                                               Tel-Aviv, Israel

Sep 2016 – Aug 2017   Senior House Officer in Ortho-Geriatrics

                                               Colchester University Hospital, NHS Foundation trust

Aug 2015 – Aug 2016   Year 2 Doctor

                                               NHS Greater Glasgow and Clyde

                                               Rotations in the following specialties: 

                                               General Medicine, Obstetrics and Gynaecology, Trauma & Orthopaedics

Aug 2014 – Aug 2015   Year 1 Doctor

                                               NHS Greater Glasgow and Clyde

                                               Rotations in the following specialties:

                                               General Medicine, General Surgery (skin cancer clinics and minor ops)

Other activity

• Clinical Tutor: 

1. Demonstrator - skin biopsy course
   St John’s Derm-academy London (June 2022)
2. Lecturer for the topic: Non-melanoma skin cancer for the MSc Dermatology, King’s College London (Aug 2021)
3. Instructor and tutor responsible for the St. George’s, University of London (Cyprus campus) and Tel-Aviv University medical students on rotation at the Dermatology department, Sheba medical centre (Sep 2018 – present) 
    
4. Delivering weekly tutorials to 5th year medical students of the University of Glasgow. Topic:  Skin cancers and melanoma (Jan 2015 – Aug 2016)

• Medical Student – Scholarship: University of Oxford, fully funded Clinical Elective at the department of Plastic Surgery – John Radcliffe University Hospital (Sep – Nov 2013)
  
   
• Medical Student – Elective: International Medical students Association funded elective, Plastic surgery – Ljubljana University Hospital (Sep 2012)
  
   
• Conferences and Courses

May 2022                      British Society of Skin Care in Immunosuppressed Individuals

                                          Update on skin diseases in immunosuppressed - London

Oct 2021                        British society of dermatological surgery course – London 

Sep 2021                        St John’s Academy dermoscopy course - London

Dec 2019                        International nail disorders conference – Tel-Aviv

Sep 2019                        Annual Dermoscopy course – Tel-Aviv

Sep 2018                       27th  EADV congress - Paris

Feb 2016                        Basic Surgical Skills course

                                           Royal College of Surgeons of Edinburgh (RCSEd)

Aug 2015                       Training the Clinical Teacher Diploma 

                                           University College London (UCL)

Sep 2013                        Head and neck flap course - NHS Oxford Deanery

Memberships and Registration

• Cyprus Medical Council
• Dermatology and Venereology specialist register
•  
• General Medical Council, UK
• Full registration 
•  
• European Academy of Dermatology and Venereology (EADV)

Specializations

Cancer Surgery

Pancreatic Surgery

Bile Duct Surgery

Bariatric Metabolic Surgery

Oncological Surgery

Breast Surgery

Gastric cancer

Colon cancer

Thyroid Cancer

Obesity Surgery

Diabetes Surgeries

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Erkan Karatas is an ENT and maxillofacial surgeon at Atlas University Hospital in Istanbul. He specializes in skull base surgery and cochlear implant placement. Dr. Karatas has contributed to over 100 medical articles. He completed specialized training at prestigious centers in the US, Germany, Italy, and Switzerland.

• Member of 11 professional associations, including the American Academy of Otolaryngology.
• Expert in complex surgeries for thyroid, tongue, and larynx cancers.
• Performs specialized procedures like stapedectomy, tympanoplasty, and orthognathic surgery.
• Works at an AACI-accredited hospital that treats 565,000 patients annually.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

この医師は乳がんと内分泌治療を専門としており、補助療法および転移性疾患におけるホルモン療法への抵抗を克服することに焦点を当てています。乳がんおよびメラノーマに関する第1相、第2相、第3相の研究に積極的に参加しており、パルボシクリブやリボシクリブのようなcdk4/6阻害剤を含む新薬の承認に貢献しています。これらは転移性乳がんのためのものであり、ペムブロリズマブ、ニボルマブ、イピリムマブのような免疫療法治療はメラノーマのためのものです。この医師は、バル・デ・エブロン大学病院およびバル・デ・エブロン腫瘍学研究所の乳がんユニットおよびメラノーマユニットのメンバーです。<\/p>

Michael Lotem heads the Center for Melanoma and Cancer Immunotherapy at Hadassah Medical Center. He specializes in clinical and pediatric oncology. The doctor researches the anti-cancer immune response.

Melanoma Treatment & Research

Dr. Lotem treats melanoma using immunotherapies. He studies the SLAM family of receptors to improve how the immune system fights cancer. This research helps find new ways to target malignant cells. He leads a team of clinicians and translational researchers in Jerusalem.

The doctor uses patient-derived tissues and clinical data for his studies. This access lets his team move laboratory findings into patient care. Dr. Lotem also performs melanoma surgery and sarcoma immunotherapy. He has worked at Hadassah Medical Center since 1995.

Clinical Focus

• Melanoma treatment and surgery
• Sarcoma immunotherapy
• Cancer screening and diagnostics
• Immune response research

Work Experience

• Head of the Center for Melanoma and Cancer Immunotherapy – Hadassah Medical Center, Jerusalem
• Professor and clinician – Hadassah Medical Center since 1995

Specialization

• Clinical Oncology
• Pediatric Oncology
• Dermatology
• Immunology

Chief Physician of the Oncology Center, Oncologist